24 results on '"Hagemeister, Fredrick"'
Search Results
2. A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas
3. Phase 2 Trial of Rituximab Plus Hyper-Cvad Alternating With Rituximab Plus Methotrexate-Cytarabine for Relapsed Or Refractory Aggressive Mantle Cell Lymphoma
4. Phase 2 Study of Gemcitabine in Combination With Rituximab in Patients With Recurrent Or Refractory Hodgkin Lymphoma
5. Pretransplant Positive Positron Emission Tomography/Gallium Scans Predict Poor Outcome in Patients With Recurrent/Refractory Hodgkin Lymphoma
6. Hodgkin Transformation of Chronic Lymphocytic Leukemia: The M. D. Anderson Cancer Center experience
7. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
8. Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
9. Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen
10. Thalidomide for patients with reccurent lymphoma
11. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease
12. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin-vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone: application of prognostic models to data analysis
13. Surgical debulking is associated with improved survival in stage I-II diffuse large cell lymphoma
14. Treatment of lower torso Stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone
15. Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma
16. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease
17. Role of the gallium scan in Hodgkin's disease
18. Reassessment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy
19. Treatment of patients with stages I and II nonmediastinal Hodgkin's disease
20. Incidence of lymphoma in the US classified by the working formulation
21. Diagnosis and management of Hodgkin's disease in the adult
22. Combined modality therapy in stage III and stage IIIE diffuse large cell lymphomas
23. Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin
24. Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.